Pascal and Francis Bibliographic Databases

Help

Search results

Your search

is.\*:("1381-6128")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4623

  • Page / 185
Export

Selection :

  • and

Anti-HIV Drug Development: Structural Features and Limitations of Present Day Drugs and Future Challenges in the Successful HIV/AIDS Treatment : The Development of Novel Inhibitors for the Treatment of HIV InfectionKUMARI, Garima; SINGH, Ramendra K.Current pharmaceutical design (Print). 2013, Vol 19, Num 10, pp 1767-1783, issn 1381-6128, 17 p.Article

Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment : Cellular Senescence and Inflammation: Advances and Therapeutic Targets in Aging and Major Age-Related DiseasesOLIVIERI, Fabiola; RECCHIONI, Rina; MARCHESELLI, Fiorella et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 9, pp 1710-1719, issn 1381-6128, 10 p.Article

Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks : Molecular Chaperones as Drug TargetsCAPPELLO, Francesco; ANGILERI, Francesca; DE MACARIO, Everly Conway et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 3, pp 452-457, issn 1381-6128, 6 p.Article

Clopidogrel, Aspirin and Proton Pump Inhibition after Percutaneous Valve Implants: An Update : Current Situation at Perioperative of Cardiovascular Disease Patients: New Addressing and Perioperative Optimization TechniquesFUSARI, Melissa.Current pharmaceutical design (Print). 2013, Vol 19, Num 22, pp 3932-3945, issn 1381-6128, 14 p.Article

Cullin-RING Ligases as Attractive Anti-cancer Targets : Targeting the Ubiquitin-Proteasome Pathway - Current Perspectives and Future DirectionsYONGCHAO ZHAO; YI SUN.Current pharmaceutical design (Print). 2013, Vol 19, Num 18, pp 3215-3225, issn 1381-6128, 11 p.Article

Detection of Gram-Negative β-Lactamase Producing Pathogens in the Clinical Lab : Resistance in Gram-negative Pathogens: A Threat to global HealthTHOMSON, Kenneth S.Current pharmaceutical design (Print). 2013, Vol 19, Num 2, pp 250-256, issn 1381-6128, 7 p.Article

Development of Small Molecule HIV-1 Fusion Inhibitors: Linking Biology to Chemistry : The Development of Novel Inhibitors for the Treatment of HIV InfectionMIYAMOTO, Fusako; KODAMA, Eiichi N.Current pharmaceutical design (Print). 2013, Vol 19, Num 10, pp 1827-1834, issn 1381-6128, 8 p.Article

Differential Influences of Gastric Bypass and Sleeve Gastrectomy on Plasma Nesfatin-1 and Obestatin Levels in Patients with Type 2 Diabetes MellitusLEE, Wei-Jei; CHEN, Chih-Yen; SER, Kong-Han et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 32, pp 5830-5835, issn 1381-6128, 6 p.Article

Factors Affecting Residual Platelet Aggregation in Prasugrel Treated PatientsALEXOPOULOS, Dimitrios; XANTHOPOULOU, Ioanna; PERPERIS, Angelos et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 28, pp 5121-5126, issn 1381-6128, 6 p.Article

From Bortezomib to other Inhibitors of the Proteasome and Beyond : The Ubiquitin Proteasome System as a Source of Drugs Targets for Cancer TherapyBUAC, Daniela; MIN SHEN; SCHMITT, Sara et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 22, pp 4025-4038, issn 1381-6128, 14 p.Article

Functional and Structural Alterations of Large Arteries: Methodological Issues : Modifying Cardiovascular Risk Factors: New Markers of Cardiovascular DamageBIANCHINI, Elisabetta; GIANNARELLI, Chiara; BRUNO, Rosa Maria et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 13, pp 2390-2400, issn 1381-6128, 11 p.Article

Gastroenterological Complications of Anderson-Fabry Disease : Anderson Fabry Disease: A Multiorgan Metabolic Disease Susceptible of TreatmentBUDA, Piotr; KSIAZYK, Janusz; TYLKI-SZYMANSKA, Anna et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 6009-6013, issn 1381-6128, 5 p.Article

HSP60 as a Drug Target : Molecular Chaperones as Drug TargetsNAKAMURA, Hiroyuki; MINEGISHI, Hidemitsu.Current pharmaceutical design (Print). 2013, Vol 19, Num 3, pp 441-451, issn 1381-6128, 11 p.Article

Heat Shock Protein 90 Inhibitors as Broad Spectrum Anti-Infectives : Molecular Chaperones as Drug TargetsROCHANI, Ankit K; SINGH, Meetali; TATU, Utpal et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 3, pp 377-386, issn 1381-6128, 10 p.Article

How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes? : Achieving Curent Goals in Prevention and Treatment of Vascular Disease: An UpdateTSIMIHODIMOS, Vasilios; FLORENTIN, Matilda; ELISAF, Moses S et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 21, pp 3773-3787, issn 1381-6128, 15 p.Article

Hsp70s and J Proteins of Plasmodium Parasites Infecting Rodents and Primates: Structure, Function, Clinical Relevance, and Drug Targets : Molecular Chaperones as Drug TargetsNJUNGE, James M; LUDEWIG, Michael H; BOSHOFF, Aileen et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 3, pp 387-403, issn 1381-6128, 17 p.Article

Identification and Usage of Fluorescent Probes as Nanoparticle Contrast Agents in Detecting CancerMANIKANTA SWAMY MURAHARI; YERGERI, Mayur C.Current pharmaceutical design (Print). 2013, Vol 19, Num 25, pp 4622-4640, issn 1381-6128, 19 p.Article

Infections and Atheromatous Plaque: Current Therapeutic Implications : Stable Angina Pectoris: Novel Therapeutics InsightsCHARAKIDA, Marietta; TOUSOULIS, Dimitris.Current pharmaceutical design (Print). 2013, Vol 19, Num 9, pp 1638-1650, issn 1381-6128, 13 p.Article

MicroRNA in the Pathogenesis and Prognosis of Esophageal Cancer : miRNA in the Pathogenesis and Therapy for Gastrointestinal and Hepatic CancersJIAN GU; YAN WANG; XIFENG WU et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 7, pp 1292-1300, issn 1381-6128, 9 p.Article

Mitochondrial Mutations in Atherosclerosis: New Solutions in Research and Possible Clinical Applications : Novel Targets and Biomarkers for Anti-atherosclerotic TherapySOBENIN, Igor A; CHISTIAKOV, Dimitry A; BOBRYSHEV, Yuri V et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5942-5953, issn 1381-6128, 12 p.Article

Modern Treatment of Infection and Ischaemia to Reduce Major Amputation in the Diabetic Foot : Diabetes, Obesity and Vascular Disease - An UpdateEDMONDS, Michael.Current pharmaceutical design (Print). 2013, Vol 19, Num 27, pp 5008-5015, issn 1381-6128, 8 p.Article

Rational Drug Design: The Search for Ras Protein Hydrolysis Intermediate Conformation Inhibitors with Both Affinity and Specificity : Rational Drug Design with the Aid of Molecular Modeling and BioinformaticsXILIANG ZHENG; ZUOJIA LIU; DAN LI et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 12, pp 2246-2258, issn 1381-6128, 13 p.Article

Substrates for Improved Live-Cell Fluorescence Labeling of SNAP-tag : The SNAP-tag Technology - A Versatile Tool with many ApplicationsCORREA, Ivan R; BAKER, Brenda; AIHUA ZHANG et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 30, pp 5414-5420, issn 1381-6128, 7 p.Article

T Cell Replicative Senescence in Human Aging : Cellular Senescence and Inflammation: Advances and Therapeutic Targets in Aging and Major Age-Related DiseasesCHOU, Jennifer P; EFFROS, Rita B.Current pharmaceutical design (Print). 2013, Vol 19, Num 9, pp 1680-1698, issn 1381-6128, 19 p.Article

T Cell-based Therapies for Atherosclerosis : Novel Targets and Biomarkers for Anti-atherosclerotic TherapyKETELHUTH, Daniel F. J; GISTERA, Anton; JOHANSSON, Daniel K et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5850-5858, issn 1381-6128, 9 p.Article

  • Page / 185